Belantamab Mafodotin OverviewBelantamab mafodotin, sold under the brand name Blenrep, is a medication for the treatment of relapsed and refractory multiple myeloma. The most common adverse reactions include keratopathy (corneal epithelium change on eye exam), decreased visual acuity, nausea, blurred vision, pyrexia, infusion-related reactions, and fatigue. Belantamab mafodotin is a humanized IgG1κ monocl...
Read more Belantamab Mafodotin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belantamab_mafodotin
Recent Belantamab Mafodotin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 2.5mg/kg
Other drugs which contain Belantamab Mafodotin or a similar ingredient: (1 result)
- BLENREP Belantamab Mafodotin-blmf